Cargando…
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
Activating mutations in the RAS family or BRAF frequently occur in many types of human cancers but are rarely detected in breast tumors. However, activation of the RAS-RAF-MEK-ERK Mitogen-Activated Protein Kinase (MAPK) pathway is commonly observed in human breast cancers, suggesting that other gene...
Autores principales: | Shrestha, Yashaswi, Schafer, Eric J., Boehm, Jesse S., Thomas, Sapana R., He, Frank, Du, Jinyan, Wang, Shumei, Barretina, Jordi, Weir, Barbara A., Zhao, Jean J., Polyak, Kornelia, Golub, Todd R., Beroukhim, Rameen, Hahn, William C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3291810/ https://www.ncbi.nlm.nih.gov/pubmed/22105362 http://dx.doi.org/10.1038/onc.2011.515 |
Ejemplares similares
-
TRAF2 is an NF-κB activating oncogene in epithelial cancers
por: Shen, Rhine R., et al.
Publicado: (2013) -
Patient-derived xenografts undergo murine-specific tumor evolution
por: Ben-David, Uri, et al.
Publicado: (2017) -
Functional Deficits in Pak5, Pak6 and Pak5/Pak6 Knockout Mice
por: Furnari, Melody A., et al.
Publicado: (2013) -
LGG-59. Identifying hidden drivers of low-grade glioma tumor growth
por: Misek, Sean, et al.
Publicado: (2022) -
PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
por: Slack-Davis, Jill K., et al.
Publicado: (2003)